Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001921094-23-001013
Filing Date
2023-12-07
Accepted
2023-12-07 16:46:58
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2933
  Complete submission text file 0001921094-23-001013.txt   4424
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 7814399100
Kiniksa Pharmaceuticals, Ltd. (Subject) CIK: 0001730430 (see all company filings)

EIN.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-38492 | Film No.: 231472904
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O KINIKSA PHARMACEUTICALS, LTD. CLARENDON HOUSE, 2 CHURCH STREET HAMILTON D0 HM11
Business Address
Paolini John F. (Reporting) CIK: 0001741533 (see all company filings)

Type: 144